ArticleCureus2026
Cutaneous Groin Metastasis as a Rare Presentation of Advanced Urothelial Carcinoma of the Bladder.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous metastases from urothelial carcinoma are rare and, when present, are associated with a poor prognosis. We report the case of a 70-year-old male with advanced urothelial carcinoma who developed biopsy-proven cutaneous metastases to the groin. The patient initially presented with hypoxia, worsening cancer-related pain, and a left groin rash. Before hospitalization, he had been treated with chemotherapy, radical cystectomy with ileal conduit, and pembrolizumab. Following discontinuation of immunotherapy because of immune-related toxicity, he later presented with hypoxia, worsening cancer-related pain, and a new groin rash that was ultimately confirmed to represent cutaneous metastasis. Imaging obtained during hospitalization revealed progression of metastatic disease involving the mediastinal lymph nodes, lungs, and bone. The patient ultimately died of disease progression. This case highlights the importance of recognizing atypical metastatic presentations, managing immunotherapy-related toxicities, and incorporating early palliative care discussions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.